食品伙伴網(wǎng)訊  據(jù)美國(guó)公益科學(xué)中心（CSPI）網(wǎng)站消息，6月25日美國(guó)公益科學(xué)中心要求FDA對(duì)能量飲料相關(guān)的心臟病、痙攣等不良反應(yīng)實(shí)施標(biāo)簽警示。

    美國(guó)公益科學(xué)中心稱，自2012年底以來，17起未報(bào)告的死亡病例被認(rèn)為跟咖啡因飲料，也就是能量飲料有關(guān)聯(lián)。

    作為進(jìn)一步的預(yù)防措施，該組織還要求制造商將能量飲料中的咖啡因含量降至0.02%或每12盎司71毫克，同時(shí)要求對(duì)能量飲料中使用的各種化學(xué)和草藥成分的安全效應(yīng)及與咖啡因可能的相互作用進(jìn)一步研究。

    部分原文報(bào)道如下：

    CSPI today asked FDA commissioner Margaret Hamburg to require warning labels on energy drink containers notifying consumers of the risk of heart attack, convulsion, and other adverse reaction to energy drinks. As a further precaution, the group asked the agency to require manufacturers to lower caffeine levels in the drinks to 0.02 percent, or 71 milligrams per 12 ounces-the maximum amount the FDA considers safe in cola-style beverages. Also, CSPI asked the agency to require careful studies on the health effects of the various chemical and herbal ingredients （such as taurine, glucuronolactone, carnitine, ginseng, ginkgo biloba, milk thistle extract, and guarana seed） used in energy drinks and their possible interactions with caffeine.

    原文鏈接：<https://www.cspinet.org/new/201406251.html>